ResMed Operating Margin 2006-2019 | RMD
Current and historical operating margin for ResMed (RMD) over the last 10 years. The current operating profit margin for ResMed as of December 31, 2019 is 20.72%.
| ResMed Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2019-12-31 | $2.78B | $0.65B | 23.24% |
| 2019-09-30 | $2.70B | $0.61B | 22.45% |
| 2019-06-30 | $2.61B | $0.58B | 22.22% |
| 2019-03-31 | $2.53B | $0.61B | 23.96% |
| 2018-12-31 | $2.46B | $0.58B | 23.79% |
| 2018-09-30 | $2.41B | $0.57B | 23.83% |
| 2018-06-30 | $2.34B | $0.54B | 23.15% |
| 2018-03-31 | $2.27B | $0.52B | 22.96% |
| 2017-12-31 | $2.20B | $0.49B | 22.45% |
| 2017-09-30 | $2.13B | $0.44B | 20.89% |
| 2017-06-30 | $2.07B | $0.43B | 20.57% |
| 2017-03-31 | $2.03B | $0.42B | 20.56% |
| 2016-12-31 | $1.97B | $0.41B | 21.04% |
| 2016-09-30 | $1.89B | $0.43B | 22.45% |
| 2016-06-30 | $1.84B | $0.43B | 23.32% |
| 2016-03-31 | $1.77B | $0.41B | 23.11% |
| 2015-12-31 | $1.74B | $0.41B | 23.65% |
| 2015-09-30 | $1.71B | $0.41B | 24.15% |
| 2015-06-30 | $1.68B | $0.41B | 24.43% |
| 2015-03-31 | $1.64B | $0.41B | 24.88% |
| 2014-12-31 | $1.62B | $0.41B | 25.19% |
| 2014-09-30 | $1.58B | $0.40B | 25.55% |
| 2014-06-30 | $1.56B | $0.41B | 26.05% |
| 2014-03-31 | $1.56B | $0.39B | 25.27% |
| 2013-12-31 | $1.54B | $0.38B | 24.92% |
| 2013-09-30 | $1.53B | $0.37B | 24.19% |
| 2013-06-30 | $1.52B | $0.35B | 23.35% |
| 2013-03-31 | $1.47B | $0.36B | 24.30% |
| 2012-12-31 | $1.44B | $0.34B | 23.57% |
| 2012-09-30 | $1.39B | $0.31B | 22.53% |
| 2012-06-30 | $1.37B | $0.30B | 21.55% |
| 2012-03-31 | $1.34B | $0.27B | 20.31% |
| 2011-12-31 | $1.30B | $0.26B | 19.88% |
| 2011-09-30 | $1.28B | $0.26B | 20.53% |
| 2011-06-30 | $1.24B | $0.27B | 21.48% |
| 2011-03-31 | $1.19B | $0.27B | 22.55% |
| 2010-12-31 | $1.16B | $0.27B | 22.95% |
| 2010-09-30 | $1.13B | $0.25B | 22.52% |
| 2010-06-30 | $1.09B | $0.24B | 22.05% |
| 2010-03-31 | $1.05B | $0.23B | 21.84% |
| 2009-12-31 | $1.00B | $0.22B | 22.16% |
| 2009-09-30 | $0.95B | $0.21B | 21.79% |
| 2009-06-30 | $0.92B | $0.19B | 20.74% |
| 2009-03-31 | $0.90B | $0.17B | 18.81% |
| 2008-12-31 | $0.89B | $0.15B | 17.34% |
| 2008-09-30 | $0.87B | $0.15B | 17.05% |
| 2008-06-30 | $0.84B | $0.14B | 17.11% |
| 2008-03-31 | $0.79B | $0.14B | 17.93% |
| 2007-12-31 | $0.76B | $0.08B | 10.88% |
| 2007-09-30 | $0.74B | $0.09B | 11.79% |
| 2007-06-30 | $0.72B | $0.09B | 12.57% |
| 2007-03-31 | $0.70B | $0.09B | 13.22% |
| 2006-12-31 | $0.68B | $0.15B | 22.37% |
| 2006-09-30 | $0.64B | $0.14B | 22.08% |
| 2006-06-30 | $0.61B | $0.13B | 21.78% |
| 2006-03-31 | $0.56B | $0.12B | 21.07% |
| 2005-12-31 | $0.51B | $0.11B | 21.34% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $21.301B | $2.607B |
| ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $139.153B | 24.35 |
| Medtronic (MDT) | Ireland | $120.856B | 16.25 |
| Stryker (SYK) | United States | $62.405B | 20.16 |
| Boston Scientific (BSX) | United States | $45.558B | 20.52 |
| Baxter (BAX) | United States | $41.185B | 25.14 |
| Coloplast (CLPBY) | Denmark | $31.169B | 48.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $30.852B | 0.00 |
| Terumo (TRUMY) | Japan | $26.431B | 32.99 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $23.407B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.863B | 12.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.690B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $15.104B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.490B | 49.03 |
| Insulet (PODD) | United States | $10.415B | 637.23 |
| William Demant Holdings (WILYY) | Denmark | $7.898B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.329B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.739B | 19.38 |
| Perrigo (PRGO) | Ireland | $6.546B | 11.93 |
| GN STORE NORD (GNNDY) | Denmark | $6.057B | 31.29 |
| Canopy Growth (CGC) | Canada | $5.038B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Haemonetics (HAE) | United States | $5.013B | 30.85 |
| ICU Medical (ICUI) | United States | $4.192B | 27.38 |
| Quidel (QDEL) | United States | $4.096B | 35.96 |
| Neogen (NEOG) | United States | $3.531B | 59.81 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.708B | 0.00 |
| NuVasive (NUVA) | United States | $2.642B | 20.43 |
| Agios Pharmaceuticals (AGIO) | United States | $2.431B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.381B | 0.00 |
| Envista Holdings (NVST) | United States | $2.373B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.558B | 26.24 |
| AtriCure (ATRC) | United States | $1.345B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.241B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.103B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.077B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.978B | 19.34 |
| NanoString Technologies (NSTG) | United States | $0.890B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.874B | 18.17 |
| Aphria (APHA) | $0.818B | 0.00 | |
| Cerus (CERS) | United States | $0.754B | 0.00 |
| Omeros (OMER) | United States | $0.725B | 0.00 |
| InMode (INMD) | Israel | $0.687B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.684B | 123.08 |
| OraSure Technologies (OSUR) | United States | $0.667B | 82.77 |
| PetIQ (PETQ) | United States | $0.657B | 17.87 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.629B | 37.40 |
| Owens & Minor (OMI) | United States | $0.577B | 15.78 |
| Quanterix (QTRX) | United States | $0.519B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.507B | 11.39 |
| LeMaitre Vascular (LMAT) | United States | $0.503B | 28.32 |
| Surmodics (SRDX) | United States | $0.453B | 52.06 |
| Vapotherm (VAPO) | United States | $0.397B | 0.00 |
| Zynex (ZYXI) | United States | $0.363B | 39.54 |
| Meridian Bioscience (VIVO) | United States | $0.360B | 14.48 |
| Utah Medical Products (UTMD) | United States | $0.348B | 24.88 |
| Organigram Holdings (OGI) | Canada | $0.346B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.298B | 187.50 |
| MacroGenics (MGNX) | United States | $0.286B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.271B | 0.00 |
| HEXO (HEXO) | $0.238B | 0.00 | |
| Female Health (VERU) | United States | $0.213B | 0.00 |
| Exagen (XGN) | United States | $0.201B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.194B | 118.75 |
| Viemed Healthcare (VMD) | United States | $0.183B | 20.70 |
| InfuSystems Holdings (INFU) | United States | $0.168B | 141.50 |
| United Health Products (UEEC) | United States | $0.148B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.142B | 0.00 |
| Evolus (EOLS) | United States | $0.140B | 0.00 |
| Bovie Medical (APYX) | United States | $0.123B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.115B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.111B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 6.86 |
| Chembio Diagnostics (CEMI) | United States | $0.091B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Brainsway (BWAY) | Israel | $0.086B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.070B | 0.00 |
| United-Guardian (UG) | United States | $0.066B | 13.89 |
| MTech Acquisition (KERN) | United States | $0.066B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.061B | 0.00 |
| Nephros (NEPH) | United States | $0.057B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.054B | 0.00 |
| Surface Oncology (SURF) | United States | $0.052B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.034B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.030B | 0.00 |
| ImmuCell (ICCC) | United States | $0.027B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.026B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.023B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.001B | 0.00 |
